Bassam Haddad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bassam Haddad has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- François Goffinet
Port Royal Maternity Hospital; Assistance Publique des Hôpitaux de Paris – Université Paris Cité; Paris France
4 shared publications - Gilles Kayem
Hôpital Trousseau, APHP, Sorbonne Université, Paris, France; OPPaLE. Obstetric, Perinatal, Paediatric Life Course Epidemiology, CRESS Paris Cité, Paris, France
3 shared publications Baha M. Sibai
Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, OH
2 shared publicationsC Louis-Sylvestre
Service de gynécologie-obstétrique, centre hospitalier intercommunal de Créteil, 40, avenue de Verdun, 94010 Créteil, France
2 shared publicationsDominique Cabrol
University Paris 5, AP-HP Cochin Port-Royal, Paris, France
2 shared publicationsEdouard Lecarpentier
Assistance publique-Hôpitaux de Paris, université Paris-Descartes, Maternité Port-Royal, centre hospitalier universitaire Cochin-Broca Hôtel-Dieu, 123, boulevard Port-Royal, 75014 Paris, France; Inserm, UMR-S 1139, 6, avenue de l'Observatoire, 75006 Paris, France; DHU risques et grossesse, 75000 Paris, France; Fondation PremUP, 123, boulevard Port-Royal, 75014 Paris, France
2 shared publications
Latest Publications
- 1 July 2016
- Published by Elsevier in La Presse Médicale
- Vol. 45 (7-8) , 638-645
Moyens thérapeutiques de la prise en charge de la pré-éclampsie
- 1 July 2016
- Published by Elsevier in La Presse Médicale
- Vol. 45 (7-8) , 638-645
Moyens thérapeutiques de la prise en charge de la pré-éclampsie
- 1 June 2014
- Vol. 64 (6) , 802-6
[Treatment of cervical cancer].
The treatment of uterine cervical cancer evolved the last past twenty years. The management of early stages cervical cancer is based on surgery +/- after an initial brachytherapy in order to increase loco-regional control. A conservative treatment preserving uterine and ovarian functions is sometimes possible for young patients < 40 years old wishing to conceive. This strategy allows pregnancies with low recurrence rate. Finally, the use of the sentinel lymph node staging should be validated within the next few years. The treatment of locally advanced stages is based on concomitant chemoradiation therapy, which allows obtaining an important complete tumour response rate (90%). Thereafter, the irradiation modalities will depend on the para-aortic lymph nodes status diagnosed by PET-computed tomography +/- staging laparoscopic para-aortic lymphadenectomy. The use of completion surgery may be indicated in case of cervical residual disease and has to be balanced with its specific morbidity. All the decisions are made during a multidisciplinary tumour board.
- 1 June 2014
- Vol. 64 (6) , 802-6
[Treatment of cervical cancer].
The treatment of uterine cervical cancer evolved the last past twenty years. The management of early stages cervical cancer is based on surgery +/- after an initial brachytherapy in order to increase loco-regional control. A conservative treatment preserving uterine and ovarian functions is sometimes possible for young patients < 40 years old wishing to conceive. This strategy allows pregnancies with low recurrence rate. Finally, the use of the sentinel lymph node staging should be validated within the next few years. The treatment of locally advanced stages is based on concomitant chemoradiation therapy, which allows obtaining an important complete tumour response rate (90%). Thereafter, the irradiation modalities will depend on the para-aortic lymph nodes status diagnosed by PET-computed tomography +/- staging laparoscopic para-aortic lymphadenectomy. The use of completion surgery may be indicated in case of cervical residual disease and has to be balanced with its specific morbidity. All the decisions are made during a multidisciplinary tumour board.
- Open Access
- 6 May 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e62140
Risk Factors of Superimposed Preeclampsia in Women with Essential Chronic Hypertension Treated before Pregnancy
To determine risk factors of superimposed preeclampsia in women with essential chronic hypertension receiving antihypertensive therapy prior to conception. A retrospective study of 211 patients that analyzed risk factors of superimposed preeclampsia at first prenatal visit. Variables with a p<.1 at univariate analysis were included in a logistic regression analysis. P<.05 was considered as significant. Superimposed preeclampsia occurred in 49 (23.2%) women. In logistic regression analysis, previous preeclampsia [OR: 4.05 (1.61–10.16)], and mean arterial blood pressure of 95 mmHg or higher [OR: 4.60 (1.94–10.93)] were associated with increased risk of superimposed preeclampsia. When both variables were present, sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratio for superimposed preeclampsia were 43%, 94%, 70%, 85%, and 7.71 (95% CI: 3.20–18.57), respectively. In essential chronic hypertensive women, previous preeclampsia and mean arterial blood pressure of 95 mmHg or higher are associated with increased risks of superimposed preeclampsia.
- 6 May 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5) , e62140
Open AccessRisk Factors of Superimposed Preeclampsia in Women with Essential Chronic Hypertension Treated before Pregnancy
To determine risk factors of superimposed preeclampsia in women with essential chronic hypertension receiving antihypertensive therapy prior to conception. A retrospective study of 211 patients that analyzed risk factors of superimposed preeclampsia at first prenatal visit. Variables with a p<.1 at univariate analysis were included in a logistic regression analysis. P<.05 was considered as significant. Superimposed preeclampsia occurred in 49 (23.2%) women. In logistic regression analysis, previous preeclampsia [OR: 4.05 (1.61–10.16)], and mean arterial blood pressure of 95 mmHg or higher [OR: 4.60 (1.94–10.93)] were associated with increased risk of superimposed preeclampsia. When both variables were present, sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratio for superimposed preeclampsia were 43%, 94%, 70%, 85%, and 7.71 (95% CI: 3.20–18.57), respectively. In essential chronic hypertensive women, previous preeclampsia and mean arterial blood pressure of 95 mmHg or higher are associated with increased risks of superimposed preeclampsia.
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S145
303: Comparison of neonatal mortality in cases of planned vaginal delivery versus planned cesarean delivery from 26 to 29 weeks gestation
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S145
303: Comparison of neonatal mortality in cases of planned vaginal delivery versus planned cesarean delivery from 26 to 29 weeks gestation
- 1 April 2010
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 29 (4) , e59-e68
Critères d’arrêt de la grossesse en cas de prééclampsie
- 1 April 2010
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 29 (4) , e59-e68
Critères d’arrêt de la grossesse en cas de prééclampsie
- 30 June 2009
- Published by Elsevier in Seminars in Perinatology
- Vol. 33 (3) , 143-151
Expectant Management in Pregnancies with Severe Pre-eclampsia
- 30 June 2009
- Published by Elsevier in Seminars in Perinatology
- Vol. 33 (3) , 143-151
Expectant Management in Pregnancies with Severe Pre-eclampsia
- 1 March 2007
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (3) , 237.e1-237.e5
Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?
- 1 March 2007
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (3) , 237.e1-237.e5
Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?
- 1 June 2005
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 48 (2) , 430-440
Expectant Management of Severe Preeclampsia: Proper Candidates and Pregnancy Outcome
- 1 June 2005
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 48 (2) , 430-440
Expectant Management of Severe Preeclampsia: Proper Candidates and Pregnancy Outcome
- 1 June 2004
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 190 (6) , 1590-1595
Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation
- 1 June 2004
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 190 (6) , 1590-1595
Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation
- 30 June 2002
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 30 (6) , 467-473
Critères d’extraction fœtale dans la prééclampsie
- 30 June 2002
- Published by Elsevier in Gynécologie Obstétrique & Fertilité
- Vol. 30 (6) , 467-473
Critères d’extraction fœtale dans la prééclampsie